Red cell distribution width in patients with HIV infection

María L. Gallego, Isabel A. Pérez-Hernández, Rosario Palacios, Josefa Ruiz-Morales, Enrique Nuño, Manuel Márquez, Jesús Santos

Unidad de Gestión Clínica de Enfermedades Infecciosas, Hospital Universitario Virgen de la Victoria, Málaga, Spain.

DOI: 10.4236/ojim.2012.21002                

Abstract

Objective: To examine the association between elevated levels of red cell distribution width (RDW) and cardiovascular risk factors (CVRF) and metabolic syndrome (MS) in HIV-patients. Methods: Cross-sectional study including all asymptomatic HIV-outpatients under follow-up during 2007. Patients completed a questionnaire about CVRF, underwent a physical examination, and an 8-hour fasting blood analysis. Elevated RDW was defined as ≥75th percentile. Patients with and without an elevated RDW were compared. Results: 666 patients (79.3% men) were included: mean age 44.7 years, mean CD4 506/mm3 and 87.5% on antiretroviral therapy (85.3% with undetectable viral load). Mean RDW was 13.7% (range: 7.7% - 33.6%; 75th percentile, 14.1%). The prevalence per quartile of MS was 15.7%, 9.3%, 18.8% and 16.6% and of patients with CVRF > 20% was 8.4%, 4.0%, 4.4%, and 6.4%, respectively (p > 0.05); 23.4% of the patients had an elevated RDW (>14.1%). The top percentile of RDW was associated with AIDS (OR 1.6; 95% CI, 1.0 - 2.4; p = 0.02), detectable viral load (OR 1.5; 95% CI, 1.01 - 2.4; p = 0.04) and hypertension (OR 2.3; 95% CI, 1.4 - 4.0; p = 0.001). Conclusions: In HIV-outpatients, higher RDW is related with detectable viral load and with AIDS. Although it was associated with hypertension, we found no relation with MS nor with higher cardiovascular risk.

Keywords

HIV; Red Cell Distribution Width; Cardiovascular Risk; Metabolic Syndrome

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	Lippi, G., Targher, G., Montagnana, M., Salvagno, G.L., Zoppini, G. and Guidi, G.C. (2009) Relation between red blood cell distribution width and inflammatory biomarkers in a large cohort of unselected outpatients. Archives of Pathology and Laboratory Medicine, 133, 628-632.
[2]	Tonelli, M., Sacks, F., Arnold, M., Moyle, L., Davis, B. and Pfeffer, M. (2008) Relation between red blood cell distribution width and cardiovascular event rate in people with coronary disease. Circulation, 117, 163-168. doi:10.1161/CIRCULATIONAHA.107.727545
[3]	Sánchez-Chaparro, M.A, Calvo-Bonacho, E., González-Quintela, A., et al. (2010) Higher red blood cell distribution width is associated with the metabolic syndrome: Results of the Ibermutuamur Cardiovascular Risk assessment study. Diabetes Care, 33, e40. doi:10.2337/dc09-1707
[4]	Felker, G.M., Allen, L.A., Pocock, S.J., et al. (2007) Red cell distribution width as a novel prognostic marker in heart failure: Data from the CHARM Program and the Duke Databank. Journal of the American College of Cardiology, 50, 40-47. doi:10.1016/j.jacc.2007.02.067
[5]	Patel, K.V., Semba, R.D., Ferrucci, L., et al. (2010) Red cell distribution width and mortality in older adults: A meta-analysis. Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 65, 258-265.
[6]	Chen, P.C., Sung, F.C., Chien, K.L., Hsu, H.C., Su, T.C. and Lee, Y.T. (2010) Red blood cell distribution width and risk of cardiovascular events and mortality in a community cohort in Taiwan. American Journal of Epidemiology, 171, 214-220. doi:10.1093/aje/kwp360
[7]	Patel, K.V., Ferrucci, L., Ershler, W.B., Longo, D.L. and Guralnik, J.M. (2009) Red cell distribution width and the risk of death in middle-aged and older adults. Archives of Internal Medicine, 169, 515-523. doi:10.1001/archinternmed.2009.11
[8]	Ye, Z., Smith, D. and Kullo, I.J. (2011) Usefulness of red cell distribution width to predict mortality in patients with peripheral artery disease. American Journal of Cardiology, 107, 1241-1245. doi:10.1016/j.amjcard.2010.12.023
[9]	Friis-M?ller, N., Reiss, P., Sabin, C.A., et al. (2007) Class of antiretroviral drugs and the risk of myocardial infarction. The New England Journal of Medicine, 356, 1723-1735. doi:10.1056/NEJMoa062744
[10]	Santos, J., Palacios, R., González, M., Ruiz, J. and Márquez, M. (2005) Atherogenic lipid profile and cardiovascular risk factors in HIV-infected patients (Nétar Study). International Journal of STD & AIDS, 16, 677- 680. doi:10.1258/095646205774357398
[11]	Baker, J.V., Neuhaus, J., Duprez, D., et al. (2011) Changes in inflammatory and coagulation biomarkers: A randomized comparison of immediate versus deferred antiretroviral therapy in patients with HIV infection. Journal of Infectious Diseases, 56, 36-43.
[12]	Calmy, A., Gayet-Ageron, A., Montecucco, F., et al. (2009) HIV increases markers of cardiovascular risk: Results of a randomized, treatment interruption trial. AIDS, 23, 929-939. doi:10.1097/QAD.0b013e32832995fa
[13]	Worm, S.W., Sabin, C., Weber, R., et al. (2010) Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: The data collection on adverse events of anti-HIV drugs (D:A:D) study. Journal of Infectious Diseases, 201, 318-330. doi:10.1086/649897
[14]	Gazzaruso, C., Sacchi, P., Garzaniti, A., Fratino, P., Bruno, R. and Filice, G. (2002) Prevalence of metabolic syndrome among HIV patients. Diabetes Care, 25, 1253-1254. doi:10.2337/diacare.25.7.1253
[15]	Palacios, R., Santos, J., González, M., Ruiz, J. and Márquez, M. (2007) Incidence and prevalence of the metabolic syndrome in a cohort of na?ve HIV-infected patients: Prospective analysis at 48 weeks of highly active antiretroviral therapy. International Journal of STD & AIDS, 18, 184-187. doi:10.1258/095646207780132415
[16]	National Cholesterol Education program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) (2002) Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation, 106, 3143-3421.
[17]	Wen, Y. (2010) High red blood cell distribution width is closely associated with risk of carotid artery atherosclerosis in patients with hypertension. Experimental & Clinical Cardiology, 15, 37-40.
[18]	Rivas, P., Górgolas, M. and Fernández-Guerrero, M.L. (2005) Zidovudine and red-cell distribution width. The New England Journal of Medicine, 352, 2141-2142. doi:10.1056/NEJM200505193522023